Skip to main content

Affimed N.V. (AFMD)

NASDAQ: AFMD · IEX Real-Time Price · USD
0.625
+0.086 (15.98%)
At close: Dec 29, 2023, 4:00 PM
0.645
+0.020 (3.20%)
After-hours: Dec 29, 2023, 7:59 PM EST

Affimed Revenue

Affimed had revenue of $20.23M in the twelve months ending September 30, 2023, down -50.08% year-over-year. Revenue in the quarter ending September 30, 2023 was $2.09M, a -85.98% decrease year-over-year. In the year 2022, Affimed had annual revenue of $43.99M, a decrease of -4.09%.

Revenue (ttm)
$20.23M
Revenue Growth
-50.08%
P/S Ratio
4.61
Revenue / Employee
$92,393
Employees
219
Market Cap
93.34M USD

Revenue Chart

* The company reports in EUR currency but revenue data is shown in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 202243.99M-1.88M
-4.09%
Dec 31, 202145.87M11.29M
32.63%
Dec 31, 202034.59M10.55M
43.90%
Dec 31, 201924.03M-3.25M
-11.90%
Dec 31, 201827.28M24.87M
1,031.03%
Dec 31, 20172.41M-4.23M
-63.70%
Dec 31, 20166.64M-1.57M
-19.10%
Dec 31, 20158.21M4.12M
100.71%
Dec 31, 20144.09M-2.90M
-41.50%
Dec 31, 20137.00M5.45M
352.11%
Dec 31, 20121.55M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Sonida Senior Living 249.13M
SCYNEXIS 135.87M
Neuronetics 69.23M
ProPhase Labs 62.71M
Bionano Genomics 33.61M
Chimerix 1.13M
Spyre Therapeutics 1.05M
Revenue Rankings

AFMD News

More News